American Century Companies’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
Other funds holding OVID
JT
EAM
RCM
AAA
ACM
American Century Companies's OVID Position: Q2 2026 in Review
American Century Companies opened a new position in Ovid Therapeutics (OVID) in Q2 2026: 169,382 shares worth $456K. The stake represents ﹤0.01% of the portfolio and ranks #2608 among its holdings. This is a return to the name: American Century Companies previously reported a position in OVID as recently as Q3 2022.
American Century Companies first reported a position in OVID in Q3 2021 and has held it in 6 quarters since. 130 funds tracked by Wall St. Rank hold OVID as of Q2 2026.
- American Century Companies held 169,382 shares of Ovid Therapeutics worth $456K as of Q2 2026.
- Ovid Therapeutics was a new American Century Companies position in Q2 2026.
- Ovid Therapeutics made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2608 holding.
- American Century Companies first reported a position in Ovid Therapeutics in Q3 2021 and has held it in 6 quarters since.
- 130 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.